We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+23.97%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$69.6B
AUM Growth
+$8.07B
Cap. Flow
+$567M
Cap. Flow %
0.82%
Top 10 Hldgs %
16.2%
Holding
2,221
New
173
Increased
863
Reduced
913
Closed
183

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$436M
2
RF icon
Regions Financial
RF
+$313M
3
ADP icon
Automatic Data Processing
ADP
+$289M
4
INTU icon
Intuit
INTU
+$288M
5
NFLX icon
Netflix
NFLX
+$253M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Healthcare 13.59%
3 Industrials 13.09%
4 Financials 10.33%
5 Consumer Discretionary 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIC icon
1601
Nicolet Bankshares
NIC
$3.59B
$110K ﹤0.01%
667
-747
-53% -$110K
S icon
1602
SentinelOne
S
$7.87B
$106K ﹤0.01%
6,226
+6,201
+24,804% +$95.4K
DLB icon
1603
Dolby
DLB
$5.8B
$105K ﹤0.01%
2,001
-780
-28% -$44.7K
AJG icon
1604
Arthur J. Gallagher & Co
AJG
$64.9B
$105K ﹤0.01%
457
-55
-11% -$11.7K
PIPR icon
1605
Piper Sandler
PIPR
$5.27B
$105K ﹤0.01%
1,446
+342
+31% +$27.7K
TBBK icon
1606
The Bancorp
TBBK
$2.05B
$103K ﹤0.01%
1,652
+164
+11% +$9.4K
CNOB icon
1607
Center Bancorp
CNOB
$1.6B
$103K ﹤0.01%
+3,091
New +$92.8K
AEHR icon
1608
Aehr Test Systems
AEHR
$2.72B
$103K ﹤0.01%
+1,076
New +$98.3K
COLL icon
1609
Collegium Pharmaceutical
COLL
$743M
$102K ﹤0.01%
2,831
+553
+24% +$18.9K
NI icon
1610
NiSource
NI
$19.7B
$102K ﹤0.01%
2,136
-2,541
-54% -$120K
BHRB icon
1611
Burke & Herbert Financial Services Corp
BHRB
$1.44B
$100K ﹤0.01%
+1,395
New +$90.2K
BLFS icon
1612
BioLife Solutions
BLFS
$1.73B
$98.7K ﹤0.01%
3,495
+493
+16% +$11.5K
NBN icon
1613
Northeast Bank
NBN
$1.14B
$98.6K ﹤0.01%
+744
New +$92K
DGX icon
1614
Quest Diagnostics
DGX
$26.3B
$98.1K ﹤0.01%
463
+2
+0.4% +$393
AME icon
1615
Ametek
AME
$53.6B
$98K ﹤0.01%
405
-578
-59% -$133K
VTRS icon
1616
Viatris
VTRS
$19.1B
$97.9K ﹤0.01%
6,167
-19,018
-76% -$295K
VMRK
1617
Vivmark Residential
VMRK
$51.3B
$96.8K ﹤0.01%
1,425
-16
-1% -$1.04K
KURA icon
1618
Kura Oncology
KURA
$1.03B
$96.6K ﹤0.01%
8,810
+638
+8% +$6.02K
LH icon
1619
Labcorp
LH
$25.6B
$96K ﹤0.01%
343
-454
-57% -$119K
AIN icon
1620
Albany International
AIN
$1.71B
$96K ﹤0.01%
1,289
CHD icon
1621
Church & Dwight Co
CHD
$22.4B
$95.9K ﹤0.01%
990
-1,256
-56% -$120K
GRBK icon
1622
Green Brick Partners
GRBK
$2.96B
$95.9K ﹤0.01%
1,198
+210
+21% +$14.5K
URBN icon
1623
Urban Outfitters
URBN
$6.6B
$95.6K ﹤0.01%
1,349
+144
+12% +$10.3K
MTCH icon
1624
Match Group
MTCH
$9.91B
$95.3K ﹤0.01%
2,504
+4
+0.2% +$142
OCFC icon
1625
OceanFirst Financial
OCFC
$1.8B
$94.6K ﹤0.01%
+4,845
New +$90.3K

Similar funds

Federated Hermes's Q2 2026 Portfolio in Review

As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
  • Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
  • Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
  • Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
  • Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
  • Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.